Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postmarketing Surveillance of Menactra in Korea
NCT02864927Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2016
- Primary completion
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of meningococcal A conjugate vaccine in meningococcal infection (2 arms), sponsored by Sanofi. Primary endpoints: Number of Participants Reporting Solicited Injection-Site Reactions Following Vaccination with Menactra®, Number of Participants Reporting Solicited Systemic Reactions Following Vaccination with Menactra® and 1 more. Started Jul 2016; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT02864927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864927.